Get started
Author

Jessica Katharina Kaufeld

Observed names: J Kaufeld, J. Kaufeld, Jessica K. Kaufeld, Jessica Kaufeld, Kaufeld, Jessica
Observed institutions: Brigham and Women's Hospital, Vanderbilt University, Klinikum St. Georg, Mount Desert Island Biological Laboratory, Medizinische Hochschule Hannover, University of Oxford, Jackson Laboratory, MRC Population Health Research Unit
ORCID: 0000-0001-7718-3464
Observed ORCID: 0000-0001-7718-3464
OpenAlex ID: A5040992538
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
2023 · Katherine R Tuttle, Sibylle J Hauske, et al. · The Lancet · 219
PDF
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
2023 · PK Judge, N Staplin, et al. · The Lancet Diabetes & Endocrinology · 137
PDF
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
2020 · Linus A. Völker, Jessica Kaufeld, et al. · Blood Advances · 122
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
2023 · N Staplin, R Haynes, et al. · The Lancet Diabetes & Endocrinology · 114
PDF
Acute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension
2016 · Karsten Heusser, Jens Tank, et al. · Hypertension · 83
PDF
Efficacy and Safety of Ravulizumab in IgA Nephropathy
2024 · Richard Lafayette, James Tumlin, et al. · Journal of the American Society of Nephrology · 80
Cofilin-1 Inactivation Leads to Proteinuria – Studies in Zebrafish, Mice and Humans
2010 · Sharon Ashworth, Beina Teng, et al. · PLoS ONE · 80
PDF
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
2020 · Linus A. Völker, Jessica Kaufeld, et al. · Blood Advances · 79
PDF
“Zebrafishing” for Novel Genes Relevant to the Glomerular Filtration Barrier
2013 · Nils Hanke, Lynne Staggs, et al. · BioMed Research International · 72
PDF
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS)
2020 · Malte Lenders, Peter Nordbeck, et al. · Clinical Pharmacology & Therapeutics · 69
Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab
2020 · Linus A. Völker, Paul T. Brinkkoetter, et al. · Journal of Thrombosis and Haemostasis · 65
PDF
Treatment of Fabry Disease management with migalastat—outcome from a prospective 24 months observational multicenter study (FAMOUS)
2021 · Malte Lenders, Peter Nordbeck, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 62
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
2023 · Linus A. Völker, Jessica Kaufeld, et al. · Journal of Thrombosis and Haemostasis · 56
PDF
Risk factors for critical limb ischemia in patients undergoing femoral cannulation for venoarterial extracorporeal membrane oxygenation: Is distal limb perfusion a mandatory approach?
2019 · Tim Kaufeld, Eric Beckmann, et al. · Perfusion · 46
PDF
Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange
2024 · Lucas Kühne, Paul Knöbl, et al. · Blood · 42
Health economic benefits through the use of diagnostic support systems and expert knowledge
2021 · Tina Willmen, Lukas Völkel, et al. · BMC Health Services Research · 31
PDF
Alternate‐day dosing of caplacizumab for immune‐mediated thrombotic thrombocytopenic purpura
2022 · Lucas Kühne, Jessica Kaufeld, et al. · Journal of Thrombosis and Haemostasis · 30
Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitoring Acute Tubular Injury in Kidney Transplant Patients: NGAL and ATI in Renal Transplant Patients
2012 · Jessica K. Kaufeld, Wilfried Gwinner, et al. · Journal of Transplantation · 30
PDF
Atypical Hemolytic and Uremic Syndrome Triggered by Infection With SARS-CoV2
2021 · Jessica Kaufeld, Martin Reinhardt, et al. · Kidney International Reports · 29
Preoperative serum uric acid predicts incident acute kidney injury following cardiac surgery
2018 · T. Kaufeld, K. A. Foerster, et al. · BMC Nephrology · 28
PDF
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
2024 · Kristina Schönfelder, Lucas Kühne, et al. · BMC Nephrology · 23
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198
2026 · Howard Trachtman, Matthias Kretzler, et al. · The Lancet · 16
Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial
2024 · Elisabeth Bahlmann-Kroll, Sebastian Häckl, et al. · BMJ Open · 13
PDF
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease
2025 · Malte Lenders, Albina Nowak, et al. · Orphanet Journal of Rare Diseases · 12
PDF
Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition
2024 · Jessica K. Kaufeld, Lucas Kühne, et al. · Kidney International Reports · 12
Works count: 78
Citation count: 1,663
H-index: 21
I10-index: 27
Year
Topic
Type